Endo R&D: Building a Sustainable Pipeline

Endo R&D is strategically expanding the company's development pipeline by adding new projects through acquisitions and in-licensing, as well as by funding product life cycle management opportunities for approved products that support clear patient benefits.

With a focus on efficient investments through concentrating resources on lower risk, nearer-term, revenue-generating projects, we aim to maintain our specialty focus across a range of therapeutic areas that includes Pain, Urology, Men's Health, Orthopedics and Endocrinology.

About Endo


Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, PA.

Visit Endo.com